MCS 18Alternative Names: MCS-18
Latest Information Update: 15 Dec 2015
At a glance
- Originator SiNatur
- Class Analgesics; Anti-inflammatories; Antirheumatics
- Mechanism of Action Dendritic cell modulators; TRPV1 receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Phase II Musculoskeletal pain
- Preclinical Atherosclerosis